Skip to main content
SpringerLink
Log in

Recent Advances in the Natural History of Dilated Cardiomyopathy: A Review of the Heart Muscle Disease Registry of Trieste

  • Chapter
Perioperative Critical Care Cardiology

Part of the book series: Topics in Anaesthesia and Critical Care ((TIACC))

  • 1594 Accesses

Abstract

Dilated cardiomyopathy (DCM) is heart muscle disease characterized by left ventricular or biventricular dilatation and impaired myocardial contractility [1]. It is an important cause of morbidity and mortality, and is one of the two most frequent indications for cardiac transplantation. The prevalence of DCM in the United States has been estimated at around 0.04% [2], with an annual incidence of 0.005–0.006% [2, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies (1996) Circulation 93:841–2

    Google Scholar 

  2. Codd MB, Sugrue DD, Gersh BJ et al (1989) Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975–1984. Circulation 80:564–72

    Google Scholar 

  3. Mestroni L, Rocco C, Gregori D et al (1999) Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 34:181–90

    Article  PubMed  CAS  Google Scholar 

  4. Gavazzi A, Lanzarini L, Cornalba C et al (1984) Dilated (congestive) cardiomyopathy. G Ital Cardiol 14:492–8

    PubMed  CAS  Google Scholar 

  5. Franciosa JA, Wilen M, Ziesche S et al (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–6

    Article  PubMed  CAS  Google Scholar 

  6. Di Lenarda A, Secoli G, Perkan A et al (1994) Changing mortality in dilated cardiomyopathy. Br Heart J 72:46–51

    Google Scholar 

  7. Di Lenarda A, Sabbadini G, Gortan R et al (2001) Has the prognosis of idiopathic dilated cardiomyopathy improved in the community? The Heart Muscle Disease Registry of Trieste (abstract). J Am Coll Cardiol 37:169A

    Google Scholar 

  8. Massa L, Vitali-Serdoz L, Di Lenarda A et al (2002) Prognostic stratification and long-term follow-up of optimally treated patients with ischemic cardiomyopathy. The Trieste HF Registry (abstract). Eur J Heart Fail 1(Suppl 1):18

    Google Scholar 

  9. Di Lenarda A, Sinagra G, Sabbadini G et al (2001) Long-term follow-up in asymptomatic dilated cardiomyopathy treated with beta-blockers. The Heart Muscle Disease Registry of Trieste (abstract) Eur Heart J 22(Suppl): 637

    Google Scholar 

  10. Michels VV, Moll PP, Miller FA et al (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326:77–82

    Article  PubMed  CAS  Google Scholar 

  11. Grunig E, Tasman JA, Kucherer H et al (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31:186–94

    Article  PubMed  CAS  Google Scholar 

  12. Gregori D, Rocco C, Miocic S, Mestroni L (2001) Estimating the frequency of familial dilated cardiomyopathy in the presence of misclassification errors. J Appl Stat 28:53–62

    Article  Google Scholar 

  13. Sinagra G, Di Lenarda A, Brodsky GL et al for the Heart Muscle Disease Study Group (2001) New insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J 2:280–6

    PubMed  CAS  Google Scholar 

  14. Kamisago M, Sharma SD, De Palma SR et al (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343:1688–96

    Article  PubMed  CAS  Google Scholar 

  15. Brodsky GL, Muntoni F, Miocic S et al (2000) A lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101:473–6

    PubMed  CAS  Google Scholar 

  16. Jacobs PM, Hanson EL, Crispell KA et al (2001) Novel lamin A/C gene mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 7:249–56

    Article  Google Scholar 

  17. Arbustini E, Pilotto A, Repetto A et al (2002) Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 39:981–90

    Article  PubMed  CAS  Google Scholar 

  18. Taylor MR, Fain PR, Sinagra G et al (2003) Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 41:771–80

    Article  PubMed  CAS  Google Scholar 

  19. Appleton CP, Hatle LK, Popp RL (1988) Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12:426–40

    PubMed  CAS  Google Scholar 

  20. Giannuzzi P, Imparato A, Temporelli PL et al (1994) Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23:1630–7

    Article  PubMed  CAS  Google Scholar 

  21. Pozzoli M, Capomolla S, Pinna G et al (1996) Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic HF with and without mitral regurgitation. J Am Coll Cardiol 27:883–93

    Article  PubMed  CAS  Google Scholar 

  22. Vanoverschelde JL, Raphael DA, Robert AR et al (1990) Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. J Am Coll Cardiol 15:1288–95

    PubMed  CAS  Google Scholar 

  23. Tabet JY, Logeart D, Geyer C et al (2000) Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic HF. Eur Heart J 21:1864–71

    Article  PubMed  CAS  Google Scholar 

  24. Pinamonti B, Di Lenarda A, Sinagra G et al (1993) Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol 22:808–15

    PubMed  CAS  Google Scholar 

  25. Pinamonti B, Zecchin M, Di Lenarda A et al (1997) Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol 29:604–12

    Article  PubMed  CAS  Google Scholar 

  26. Traversi E, Pozzoli M, Cioffi G et al (1996) Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic HF. Am Heart J 132:809–19

    Article  PubMed  CAS  Google Scholar 

  27. Temporelli PL, Corra U, Imparato A et al (1998) Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic HF. J Am Coll Cardiol 31:1591–7

    Article  PubMed  CAS  Google Scholar 

  28. Hofmann T, Meinertz T, Kasper W et al (1988) Mode of death in idiopathic dilated cardiomyopathy: multivariate analysis of prognostic determinants. Am Heart J 116:1455–63

    Article  PubMed  CAS  Google Scholar 

  29. Meinertz T, Hofmann T, Kasper W et al (1984) Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 53:902–7

    Article  PubMed  CAS  Google Scholar 

  30. Diaz RA, Obasohan A, Oakley CM (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58:393–9

    PubMed  CAS  Google Scholar 

  31. Keogh AM, Baron DW, Hickie JB. (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 65:903–8

    Article  PubMed  CAS  Google Scholar 

  32. Morgera T, Di Lenarda A, Rakar S et al (2002) Substrate and prognostic impact of ventricular tachycardia in dilated cardiomyopathy (abstract). Eur J Heart Fail 1(Suppl 1):63

    Google Scholar 

  33. Caruso AC, Marcus FI, Hahn EA et al (1997) Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Circulation 96:1888–92

    PubMed  CAS  Google Scholar 

  34. Cohn JN, Johnson G, Ziesche S et al (1991) A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive HF. N Engl J Med 325:303–10

    Article  PubMed  CAS  Google Scholar 

  35. Grimm W, Hoffmann JJ, Muller HH et al (2002) Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol 39:780–7

    Article  PubMed  Google Scholar 

  36. Zecchin M, Di Lenarda A, Bonin M et al (2001) Incidence and predictors of sudden cardiac death during long term follow-up in patients with dilated cardiomyopathy on optimal medical therapy. Ital Heart J 2:213–21

    PubMed  CAS  Google Scholar 

  37. The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with HF. N Engl J Med 336:525–33

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Department, “Ospedali Riuniti” and University of Trieste, Trieste, Italy

    M. Moretti, A. Di Lenarda & G. Sinagra

Authors
  1. M. Moretti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Di Lenarda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Sinagra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Italia

About this chapter

Cite this chapter

Moretti, M., Di Lenarda, A., Sinagra, G. (2007). Recent Advances in the Natural History of Dilated Cardiomyopathy: A Review of the Heart Muscle Disease Registry of Trieste. In: Perioperative Critical Care Cardiology. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-0558-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0558-7_16

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0557-0

  • Online ISBN: 978-88-470-0558-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation